Edition:
India

Caplin Point Laboratories Ltd (CAPL.NS)

CAPL.NS on National Stock Exchange of India

429.35INR
19 Sep 2019
Change (% chg)

-- (--)
Prev Close
Rs429.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,852
52-wk High
Rs497.35
52-wk Low
Rs296.05

Latest Key Developments (Source: Significant Developments)

Caplin Point Labs Says Caplin Steriles Gets USFDA Approval For Tranexamic Acid Injection
Thursday, 18 Jul 2019 

July 18 (Reuters) - Caplin Point Laboratories Ltd ::SAYS CAPLIN STERILES GETS USFDA APPROVAL FOR TRANEXAMIC ACID INJECTION.  Full Article

India's Caplin Point Laboratories Dec-Qtr Consol Profit Rises
Monday, 11 Feb 2019 

Feb 11 (Reuters) - Caplin Point Laboratories Ltd ::DEC QUARTER CONSOL NET PROFIT 458.3 MILLION RUPEES VERSUS PROFIT 375.2 MILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 1.59 BILLION RUPEES VERSUS 1.42 BILLION RUPEES YEAR AGO.  Full Article

Says Caplin Point Laboratories And Hainan Jointown Pharmaceutical Signs JV Deal
Friday, 14 Sep 2018 

Sept 14 (Reuters) - Caplin Point Laboratories Ltd ::CO, HAINAN JOINTOWN PHARMACEUTICAL SIGNS JV DEAL TO ESTABLISH HAINAN JOINTOWN CAPLINPOINT PHARMACEUTICAL IN HAIKOU CITY.  Full Article

India's Caplin Point Labs Dec-Qtr Consol Profit Rises
Wednesday, 7 Feb 2018 

Feb 7 (Reuters) - Caplin Point Laboratories Ltd ::DEC QUARTER CONSOL NET PROFIT 375.2 MILLION RUPEES VERSUS PROFIT 237.6 MILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 1.42 BILLION RUPEES VERSUS 1.03 BILLION RUPEES YEAR AGO.  Full Article

India's Caplin Point Laboratories Sept-qtr consol profit rises
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Caplin Point Laboratories Ltd ::Sept quarter consol profit 355.7 million rupees versus profit of 224.1 million rupees year ago.Sept quarter consol revenue from operations 1.31 billion rupees versus 957.2 million rupees year ago.  Full Article